212 related articles for article (PubMed ID: 4369604)
1. [Lesions of the uterine cervix during oral contraception].
De Brux J
Sem Hop; 1974 May; 50(22):1491-5. PubMed ID: 4369604
[No Abstract] [Full Text] [Related]
2. [Oral estro-progestational agents and the uterine cervix].
de Brux J
Pathol Eur; 1972; 7(3):283-7. PubMed ID: 4657185
[No Abstract] [Full Text] [Related]
3. Complications of systemic oral contraceptive therapy: Neoplasm--breast, uterus, cervix and vagina.
Sperling MA
West J Med; 1975 Jan; 122(1):42-9. PubMed ID: 1089006
[No Abstract] [Full Text] [Related]
4. Relationship of oral contraceptives to cervical carcinogenesis.
Thomas DB
Obstet Gynecol; 1972 Oct; 40(4):508-18. PubMed ID: 5073446
[No Abstract] [Full Text] [Related]
5. Oral contraceptives: relations to mammary cancer, benign breast lesions, and cervical cancer.
Drill VA
Annu Rev Pharmacol; 1975; 15():367-85. PubMed ID: 1096791
[TBL] [Abstract][Full Text] [Related]
6. [Oral contraception and cancers of the uterus and the breast].
Vokaer R
J Gynecol Obstet Biol Reprod (Paris); 1974; 3(3):379-400. PubMed ID: 4470735
[No Abstract] [Full Text] [Related]
7. [Colpocytological patterns caused by hormonal contraceptives].
Pescetto G; Ragni N
Minerva Ginecol; 1975 Jun; 27(6):433-9. PubMed ID: 1153120
[TBL] [Abstract][Full Text] [Related]
8. [Therapy damage in gynecology. (Clinical observations of the effects of female sexual hormones and of compounds with similar action) (report) (author's transl)].
Ober KG
Verh Dtsch Ges Pathol; 1972; 56():283-91. PubMed ID: 4130830
[No Abstract] [Full Text] [Related]
9. [The effect of oral hormonal contraception on the incidence of carcinoma and dysplasia of the cervix].
Kovacic J; Andolsek L; Kozuh M; Litt B
Jugosl Ginekol Opstet; 1981; 21(1-2):11-6. PubMed ID: 7052391
[No Abstract] [Full Text] [Related]
10. Oral contraceptives and endometrial and cervical cancer.
Moghissi KS
J Toxicol Environ Health; 1977 Sep; 3(1-2):243-65. PubMed ID: 336901
[No Abstract] [Full Text] [Related]
11. Oral contraceptives and cervical cancer. A preliminary report of an experimental study.
Myhre E; Bjoro K
Acta Pathol Microbiol Scand; 1969; 76(3):495-6. PubMed ID: 5823365
[No Abstract] [Full Text] [Related]
12. Experimental and clinical aspects of the carcinogenic potential of steroid contraceptives.
Hertz R
Int J Fertil; 1968; 13(4):273-86. PubMed ID: 4882601
[No Abstract] [Full Text] [Related]
13. Cancer risks from estrogen intake.
Greenwald P; Nasca PC; Caputo TA; Janerich DT
N Y State J Med; 1977 Jun; 77(7):1069-74. PubMed ID: 267252
[No Abstract] [Full Text] [Related]
14. Oral contraception. Physiologic and pathologic effects.
Andrews WC
Obstet Gynecol Annu; 1978; 7():325-51. PubMed ID: 351485
[No Abstract] [Full Text] [Related]
15. [Oral contraceptives and cancer of the cervix uteri. Analysis of the strength of the association].
Rodríguez-Contreras R; Delgado Rodríguez M; Sillero Arenas M; Lardelli Claret P; Gálvez Vargas R
Rev Sanid Hig Publica (Madr); 1991; 65(1):25-38. PubMed ID: 1839333
[TBL] [Abstract][Full Text] [Related]
16. [Carcinoma in situ and cervical carcinoma during the use of oral contraceptives].
Wunder G
Fortschr Med; 1973 Sep; 91(27):1082-4. PubMed ID: 4746761
[No Abstract] [Full Text] [Related]
17. Cervical carcinoma and oral contraception.
Boyce JG; Lu T; Nelson JH; Joyce D
Obstet Gynecol; 1972 Aug; 40(2):139-46. PubMed ID: 5047946
[No Abstract] [Full Text] [Related]
18. [Adenocarcinoma of the cervix and the use of oral contraceptives].
Dtsch Med Wochenschr; 1995 Sep; 120(39):1341. PubMed ID: 7555649
[No Abstract] [Full Text] [Related]
19. Comparison of oral contraceptive use in women with adenocarcinoma and squamous cell carcinoma of the uterine cervix.
Honoré LH; Koch M; Brown LB
Gynecol Obstet Invest; 1991; 32(2):98-101. PubMed ID: 1748331
[TBL] [Abstract][Full Text] [Related]
20. Morphologic changes in the uterus associated with steroid contraceptives and intrauterine contraceptive devices.
Ober WB
Acta Cytol; 1970 Mar; 14(3):156. PubMed ID: 5265919
[No Abstract] [Full Text] [Related]
[Next] [New Search]
